These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2358467

  • 1. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD, Sant ME, Christopherson RI.
    J Biol Chem; 1990 Jul 05; 265(19):11377-81. PubMed ID: 2358467
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
    Rosenfeld H, Roberts J.
    Cancer Res; 1981 Apr 05; 41(4):1324-8. PubMed ID: 7214322
    [Abstract] [Full Text] [Related]

  • 3. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
    Denton JE, Lui MS, Aoki T, Sebolt J, Weber G.
    Life Sci; 1982 Mar 29; 30(13):1073-80. PubMed ID: 7078346
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of a mutant Chinese hamster cell line resistant to the glutamine analog 6-diazo-5-oxo-L-norleucine.
    Kaufman ER.
    Somat Cell Mol Genet; 1985 Jan 29; 11(1):1-10. PubMed ID: 3856328
    [Abstract] [Full Text] [Related]

  • 5. Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
    Ardalan B, Arakawa M, Villacorte D, Jayaram H, Cooney DA.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1509-13. PubMed ID: 6178415
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
    Loh E, Kufe DW.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3419-23. PubMed ID: 7260907
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
    Prajda N, Natsumeda Y, Ikegami T, Reardon MA, Szondy S, Hashimoto Y, Emrani J, Weber G.
    Biochem Pharmacol; 1988 Mar 01; 37(5):875-80. PubMed ID: 3345200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
    Jayaram HN, Cooney DA, Ryan JA, Neil G, Dion RL, Bono VH.
    Cancer Chemother Rep; 1975 Mar 01; 59(3):481-91. PubMed ID: 1147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.